FDA advisors reject Avastin as breast cancer treatment – Los Angeles Times

Posted by on Jun 30th, 2011 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

FDA advisors reject Avastin as breast cancer treatment – Los Angeles Times


USA Today

FDA advisors reject Avastin as breast cancer treatment
Los Angeles Times
The panel says studies have failed to prove the drug's effectiveness for treating breast cancer. The FDA is likely to follow the advisors' recommendation. “We are very disappointed by the committee's recommendation,” said Krysta Pellegrino,
FDA panel against use of Avastin for breast cancerSan Francisco Chronicle
FDA panel votes against Avastin for breast cancer treatmentWashington Post
Panel Backs FDA Pulling Plug on AvastinInternal Medicine News Digital Network
ABC News –Reuters –CNN
all 928 news articles »

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.